The DOI matches its Crossref record.
An Essay on the Shaking Palsy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Items 101–157 of 157
Fontana, B. D., Mezzomo, N. J., Kalueff, A. V., & Rosemberg, D. B. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.004 · Cited by 272
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation
Chaudhuri, K. R., Rizos, A., Trenkwalder, C., Rascol, O., Pal, S., Martino, D., Carroll, C., Paviour, D., Falup‐Pecurariu, C., Kessel, B., et al. (2015) · Movement Disorders · doi:10.1002/mds.26270 · Cited by 270
Sulzer, D., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0047-3 · Cited by 270
Inner Retinal Layer Thinning in Parkinson Disease
Hajee, M. E. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.106 · Cited by 268
Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study
Tanner, C. M., Ross, G. W., Jewell, S. A., Hauser, R. A., Jankovic, J., Factor, S. A., Bressman, S., Deligtisch, A., Marras, C., Lyons, K. E., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.195 · Cited by 267
Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management
OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265
Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease
Howell, M. J., & Schenck, C. H. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4563 · Cited by 261
Molecular pathogenesis of Parkinson's disease
Gandhi, S., & Wood, N. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi308 · Cited by 251
Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective
Robbins, T. W., & Cools, R. (2014) · Movement Disorders · doi:10.1002/mds.25853 · Cited by 235
The Role of α-Synuclein Oligomers in Parkinson’s Disease
Du, X.-Y., Xie, X.-X., & Liu, R.-T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228645 · Cited by 234
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00542-9 · Cited by 232
Striatal mechanisms underlying movement, reinforcement, and punishment
Kravitz, A. V., & Kreitzer, A. C. (2012) · Physiology · doi:10.1152/physiol.00004.2012 · Cited by 224
Gastrointestinal dysfunction in Parkinson's Disease
Jost, W. H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.020 · Cited by 222
Prevalence of pain in Parkinson's disease: A systematic review using the modified QUADAS tool
Broen, M. P. G., Braaksma, M. M., Patijn, J., & Weber, W. E. J. (2012) · Movement Disorders · doi:10.1002/mds.24054 · Cited by 220
Hague, K., Lento, P., Morgello, S., Caro, S., & Kaufmann, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050693 · Cited by 209
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205
Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
Dubois, B., Tolosa, E., Katzenschlager, R., Emre, M., Lees, A. J., Schumann, G., Pourcher, E., Gray, J., Thomas, G., Swartz, J., et al. (2012) · Movement Disorders · doi:10.1002/mds.25098 · Cited by 202
The serotonergic system in Parkinson's disease
Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195
microRNA Profiles in Parkinson's Disease Prefrontal Cortex
Hoss, A. G., Labadorf, A., Beach, T. G., Latourelle, J. C., & Myers, R. H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00036 · Cited by 168
Sleep Disruption in Parkinson's Disease: Assessment by Continuous Activity Monitoring
van Hilten, B. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210094018 · Cited by 166
Anxiety in Parkinson's disease: identification and management
Chen, J. J., & Marsh, L. (2014) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613495723 · Cited by 161
Anal Sphincter Dysfunction in Parkinson's Disease
Mathers, S. E., Kempster, P. A., Law, P. J., Frankel, J. P., Bartram, C. I., Lees, A. J., Stern, G. M., & Swash, M. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460037010 · Cited by 158
Williams-Gray, C. H., Foltynie, T., Lewis, S. J. G., & Barker, R. A. (2006) · CNS Drugs · doi:10.2165/00023210-200620060-00004 · Cited by 147
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, I. C., & Outeiro, T. F. (2021) · Cells · doi:10.3390/cells10020375 · Cited by 136
Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
Balestrino, R., & Martinez-Martin, P. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.060 · Cited by 135
Detecting freezing of gait with a tri-axial accelerometer in Parkinson’s disease patients
Ahlrichs, C., Samà, A., Lawo, M., Cabestany, J., Rodríguez-Martín, D., Pérez-López, C., Sweeney, D., Quinlan, L. R., Laighin, G. Ò., Counihan, T., et al. (2016) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-015-1395-3 · Cited by 128
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
A systematic review of impulse control disorders in Parkinson’s disease.
Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L., & Møller, A. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120165 · Cited by 130
Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments
Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6762528 · Cited by 130
Development, wiring and function of dopamine neuron subtypes
Garritsen, O., van Battum, E. Y., Grossouw, L. M., & Pasterkamp, R. J. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00669-3 · Cited by 128
In vivo gastric detection of α-synuclein inclusions in Parkinson's disease
Sánchez‐Ferro, Á., Rábano, A., Catalán, M. J., Rodríguez‐Valcárcel, F. C., Díez, S. F., Herreros‐Rodríguez, J., García‐Cobos, E., Álvarez‐Santullano, M. M., López‐Manzanares, L., Mosqueira, A. J., et al. (2015) · Movement Disorders · doi:10.1002/mds.25988 · Cited by 123
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
Ondo, W. G., Kenney, C., Sullivan, K., Davidson, A., Hunter, C., Jahan, I., McCombs, A., Miller, A., & Zesiewicz, T. A. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f28 · Cited by 112
Kumaran, R., & Cookson, M. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv236 · Cited by 86
Xu, S., & Pan, Z. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2020.104283 · Cited by 87
Stuebner, E., Vichayanrat, E., Low, D. A., Mathias, C. J., Isenmann, S., & Haensch, C.-A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00049 · Cited by 84
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Hare, D. J., Adlard, P. A., Doble, P. A., & Finkelstein, D. I. (2013) · Metallomics · doi:10.1039/c2mt20164j · Cited by 78
How to use pen and paper tasks to aid tremor diagnosis in the clinic
Alty, J., Cosgrove, J., Thorpe, D., & Kempster, P. (2017) · Practical Neurology · doi:10.1136/practneurol-2017-001719 · Cited by 78
Basal lamina changes in neurodegenerative disorders
Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75
Kawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71
Resting tremor classification and detection in Parkinson's disease patients
Camara, C., Isasi, P., Warwick, K., Ruiz, V., Aziz, T., Stein, J., & Bakštein, E. (2015) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2014.09.006 · Cited by 70
Tuned vibration absorber for suppression of rest tremor in Parkinson’s disease
Hashemi, S. M., Golnaraghi, M. F., & Patla, A. E. (2004) · Medical & Biological Engineering & Computing · doi:10.1007/bf02351012 · Cited by 68
Kawahata, I., Bousset, L., Melki, R., & Fukunaga, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215358 · Cited by 56
Thermoregulation in Parkinson disease
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64074-1.00043-4 · Cited by 51
Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
Hinkle, J. T., Perepezko, K., Mills, K. A., Mari, Z., Butala, A., Dawson, T. M., Pantelyat, A., Rosenthal, L. S., & Pontone, G. M. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.08.010 · Cited by 49
Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
Chavarría, C., Ivagnes, R., & Souza, J. M. (2022) · Biomolecules · doi:10.3390/biom12050655 · Cited by 47
“Parkinson’s disease (PD) is an extrapyramidal syndrome clinically characterized, as described by James Parkinson in 1817, by rigidity, tremor, and bradykinesia [1,2].”
BackgroundNovel subcellular localization for α-synuclein: possible functional consequences
Guardia-Laguarta, C., Area-Gomez, E., Schon, E. A., & Przedborski, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00017 · Cited by 44
Phenomenology and treatment of tremor disorders
Zesiewicz, T. A., & Hauser, R. A. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70039-6 · Cited by 43
Misconceptions about speech impairment in Parkinson's disease
Moreau, C., & Pinto, S. (2019) · Movement Disorders · doi:10.1002/mds.27791 · Cited by 43
The gut–brain axis in early Parkinson’s disease: from prodrome to prevention
Oliver, P. J., Civitelli, L., & Hu, M. T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13138-5 · Cited by 42
Constipation in Idiopathic Parkinson's Disease
H., J. W., & F., E. V. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310003200 · Cited by 38
Kakoty, V., K C, S., Dubey, S. K., Yang, C.-H., & Taliyan, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00144 · Cited by 33
Ernest James Phillips, T., & Maguire, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652593 · Cited by 33
Fifel, K., Piggins, H., & Deboer, T. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.02.005 · Cited by 30
SURGERY IN PARKINSON'S DISEASE DIVISION OF LATERAL PYRAMIDAL TRACT FOR TREMOR
Oliver, L. (1949) · The Lancet · doi:10.1016/s0140-6736(49)91783-3 · Cited by 30
Sleep disturbances in Parkinson's disease patients and management options
Claassen, D. (2011) · Nature and Science of Sleep · doi:10.2147/nss.s18897 · Cited by 29
Achey, M. A., Beck, C. A., Beran, D. B., Boyd, C. M., Schmidt, P. N., Willis, A. W., Riggare, S. S., Simone, R. B., Biglan, K. M., & Dorsey, E. R. (2014) · Trials · doi:10.1186/1745-6215-15-465 · Cited by 27
Chest wall volume and asynchrony in stroke and Parkinson’s disease subjects: A case-control study
Florêncio, R. B., da Nobrega, A. J. S., Lima, Í. N. D. F., Gualdi, L. P., Cabral, E. E., Fagundes, M. L. L. C., Aliverti, A., Resqueti, V. R., & Fregonezi, G. A. D. F. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216641 · Cited by 19
Metadata
- Authors
- Parkinson, J.
- Venue
- The Journal of Neuropsychiatry and Clinical Neurosciences
- Published
- 2002-05
- Volume
- 14
- Issue
- 2
- Pages
- 223-236
- ISSN
- 0895-0172 (ISSN-L)
- 1545-7222
- OpenAlex
- W2151189936
- Cited by
- 1,628
- References
- 0
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.